Fármacos agonistas del receptor de GLP-1 como factor protector frente a la enfermedad renal crónica en pacientes con diabetes mellitus tipo 2

Autor: Assunção, Izabely Lima, Gonzalez, Giuliana Maria Morais, Silva, Vanessa Marques da, Carvalho , Clara Simplício Viana de, Machado, Arlene Gama Matos, Santos, Victor Martins dos, Pascoal, Gabriela de Abreu, Forest, Giovanna Oliveira, Sousa, Jaynnara Caroline Ferreira de, Fonseca, Isabel Alice Ramos, Silva, Luciana Sousa, Mendes, Laís Pereira, Mendes , Amanda Pereira, Britto, Filipe Augusto Lopes Cajubá de, Viana, Thassia Almeida Matos, Araújo , Maria Caroline Leal Borges de, Costa, Yvilla Cristina, Nascimento, Victoria Alves do, Meinertz , Laura Felipe, Chiacchio , Gabriel Machado, Costa, Matheus Medeiros, Cipriano, Amanda Mendonça Vieira, Souza , Daniel Geovane Silva, Gonzalez , Lethícia Maria Morais, Ferreira , Glória Maria Grangeiro

Publikováno v: Research, Society and Development; Vol. 10 No. 16; e134101623517
Research, Society and Development; Vol. 10 Núm. 16; e134101623517
Research, Society and Development; v. 10 n. 16; e134101623517
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI

Type 2 diabetes mellitus (DM) develops due to peripheral insulin resistance, tied to secretory pancreatic fatigue, its pathophysiology involves genetic and environmental factors, such as poor diet and sedentary lifestyle. Diabetic patients have a ris

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::8a56f0b8390eaa96fa010c3cd5a81d0b
https://rsdjournal.org/index.php/rsd/article/view/23517